Pediatric Obesity Pharmacotherapy.

Alexandria Speakman, Farhana Ali-Geiger, Marialena Mouzaki

Journal: Gastroenterology clinics of North America 2025;54(4):745-760

PMID: 41238273

Abstract

This article summarizes the pathophysiology of obesity and focuses on certain pharmacotherapeytic agents that are currently available for the treatment of pediatric and adult obesity. Medications in earlier stages of development are briefly mentioned, and future directions are discussed.

Address: Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.; Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Primary Children's Hospital, University of Utah, 295 Chipeta Way, Room 2S010, Salt Lake City, UT 84108, USA.; Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, 3333 Burnet Avenue, Cincinnati, OH 45229, USA. Electronic address: [email protected].

DOI: 10.1016/j.gtc.2025.05.001

MeSH Terms: Humans, Pediatric Obesity, Child, Anti-Obesity Agents